Insider Transactions in Q1 2024 at X4 Pharmaceuticals, Inc (XFOR)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 11
2024
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
52,500
-100.0%
|
$0
$0.88 P/Share
|
|
Mar 11
2024
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
49,678
-6.1%
|
$0
$0.88 P/Share
|
|
Mar 11
2024
|
Arthur Taveras Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
14,235
-5.73%
|
$0
$0.88 P/Share
|
|
Mar 11
2024
|
Mary Di Biase Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
15,409
-5.02%
|
$0
$0.88 P/Share
|
|
Feb 12
2024
|
Arthur Taveras Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
787
-0.32%
|
$787
$1.01 P/Share
|
|
Feb 12
2024
|
Mary Di Biase Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,683
-1.18%
|
$3,683
$1.01 P/Share
|
|
Feb 12
2024
|
Paula Ragan President and CEO |
SELL
Open market or private sale
|
Direct |
21,695
-2.59%
|
$21,695
$1.01 P/Share
|
|
Feb 12
2024
|
Adam S. Mostafa Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
27,721
-34.56%
|
$27,721
$1.01 P/Share
|